The AI Factor: Why Cash Still Flows To European Biotech Startups

Despite concerns about startup investment overall, Biotech continues to attract VC capital. The combination of AI and biology is accelerating new treatment development

from Forbes - Entrepreneurs https://ift.tt/rWGwzKV
via IFTTT